149 related articles for article (PubMed ID: 34824149)
21. Symptoms, investigations and management of patients with cancer of the oesophagus and gastro-oesophageal junction in Australia.
Smithers BM; Fahey PP; Corish T; Gotley DC; Falk GL; Smith GS; Kiroff GK; Clouston AD; Watson DI; Whiteman DC
Med J Aust; 2010 Nov; 193(10):572-7. PubMed ID: 21077812
[TBL] [Abstract][Full Text] [Related]
22. Changing incidence of gastric and oesophageal cancer subtypes in central Switzerland between 1982 and 2007.
Schmassmann A; Oldendorf MG; Gebbers JO
Eur J Epidemiol; 2009; 24(10):603-9. PubMed ID: 19669623
[TBL] [Abstract][Full Text] [Related]
23. Population-based investigation of common and deviating patterns of gastric cancer and oesophageal cancer incidence across populations and time.
Li M; Park JY; Sheikh M; Kayamba V; Rumgay H; Jenab M; Narh CT; Abedi-Ardekani B; Morgan E; de Martel C; McCormack V; Arnold M
Gut; 2023 May; 72(5):846-854. PubMed ID: 36241389
[TBL] [Abstract][Full Text] [Related]
24. Trends in incidence rates of oesophagus and gastric cancer in Italy by subsite and histology, 1986-1997.
Orengo MA; Casella C; Fontana V; Filiberti R; Conio M; Rosso S; Tumino R; Crosignani P; De Lisi V; Falcini F; Vercelli M;
Eur J Gastroenterol Hepatol; 2006 Jul; 18(7):739-46. PubMed ID: 16772831
[TBL] [Abstract][Full Text] [Related]
25. Breast cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK, 2000-2007: a population-based study.
Walters S; Maringe C; Butler J; Rachet B; Barrett-Lee P; Bergh J; Boyages J; Christiansen P; Lee M; Wärnberg F; Allemani C; Engholm G; Fornander T; Gjerstorff ML; Johannesen TB; Lawrence G; McGahan CE; Middleton R; Steward J; Tracey E; Turner D; Richards MA; Coleman MP;
Br J Cancer; 2013 Mar; 108(5):1195-208. PubMed ID: 23449362
[TBL] [Abstract][Full Text] [Related]
26. Trends in incidence of oesophageal and stomach cancer subtypes in Europe.
Steevens J; Botterweck AA; Dirx MJ; van den Brandt PA; Schouten LJ
Eur J Gastroenterol Hepatol; 2010 Jun; 22(6):669-78. PubMed ID: 19474750
[TBL] [Abstract][Full Text] [Related]
27. Shifting incidence and survival of epithelial ovarian cancer (1995-2014): A SurvMark-2 study.
Cabasag CJ; Arnold M; Rutherford M; Ferlay J; Bardot A; Morgan E; Butler J; O'Connell DL; Nelson G; Høgdall C; Schnack T; Gavin A; Elwood M; Hanna L; Gourley C; De P; Saint-Jacques N; Mørch LS; Woods RR; Altman AD; Sykes P; Cohen PA; McNally O; Møller B; Walsh P; Morrison DS; Bray F; Soerjomataram I
Int J Cancer; 2023 May; 152(9):1763-1777. PubMed ID: 36533660
[TBL] [Abstract][Full Text] [Related]
28. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries.
Allemani C; Matsuda T; Di Carlo V; Harewood R; Matz M; Nikšić M; Bonaventure A; Valkov M; Johnson CJ; Estève J; Ogunbiyi OJ; Azevedo E Silva G; Chen WQ; Eser S; Engholm G; Stiller CA; Monnereau A; Woods RR; Visser O; Lim GH; Aitken J; Weir HK; Coleman MP;
Lancet; 2018 Mar; 391(10125):1023-1075. PubMed ID: 29395269
[TBL] [Abstract][Full Text] [Related]
29. Geographical variations in the incidence of oesophageal cancer in Sweden.
Xie SH; Mälberg K; Andersson G; Lagergren J
Scand J Gastroenterol; 2020 Mar; 55(3):258-264. PubMed ID: 32045532
[No Abstract] [Full Text] [Related]
30. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data.
Coleman MP; Forman D; Bryant H; Butler J; Rachet B; Maringe C; Nur U; Tracey E; Coory M; Hatcher J; McGahan CE; Turner D; Marrett L; Gjerstorff ML; Johannesen TB; Adolfsson J; Lambe M; Lawrence G; Meechan D; Morris EJ; Middleton R; Steward J; Richards MA;
Lancet; 2011 Jan; 377(9760):127-38. PubMed ID: 21183212
[TBL] [Abstract][Full Text] [Related]
31. Can different definitions of date of cancer incidence explain observed international variation in cancer survival? An ICBP SURVMARK-2 study.
Myklebust TÅ; Andersson T; Bardot A; Vernon S; Gavin A; Fitzpatrick D; Jerm MB; Rutherford M; Parkin DM; Sasieni P; Arnold M; Soerjomataram I; Bray F; Lambert PC; Møller B
Cancer Epidemiol; 2020 Aug; 67():101759. PubMed ID: 32544801
[TBL] [Abstract][Full Text] [Related]
32. Oesophageal cancer survival in Europe: a EUROCARE-4 study.
Gavin AT; Francisci S; Foschi R; Donnelly DW; Lemmens V; Brenner H; Anderson LA;
Cancer Epidemiol; 2012 Dec; 36(6):505-12. PubMed ID: 22910036
[TBL] [Abstract][Full Text] [Related]
33. A population-based study on intestinal and diffuse type adenocarcinoma of the oesophagus and stomach in the Netherlands between 1989 and 2015.
van der Kaaij RT; Koemans WJ; van Putten M; Snaebjornsson P; Luijten JCHBM; van Dieren JM; Cats A; Lemmens VEPP; Verhoeven RHA; van Sandick JW
Eur J Cancer; 2020 May; 130():23-31. PubMed ID: 32171106
[TBL] [Abstract][Full Text] [Related]
34. Trends in incidence of oesophageal and gastric cancer according to morphology and anatomical location, in Switzerland 1982-2011.
Feller A; Fehr M; Bordoni A; Bouchardy C; Frick H; Mousavi M; Steiner A; Arndt V; Clough-Gorr KM;
Swiss Med Wkly; 2015; 145():w14245. PubMed ID: 26661828
[TBL] [Abstract][Full Text] [Related]
35. Comparison of comorbidity prevalence in oesophageal and gastric carcinoma patients: a population-based study.
Koppert LB; Janssen-Heijnen ML; Louwman MW; Lemmens VE; Wijnhoven BP; Tilanus HW; Coebergh JW
Eur J Gastroenterol Hepatol; 2004 Jul; 16(7):681-8. PubMed ID: 15201582
[TBL] [Abstract][Full Text] [Related]
36. Diverging trends in recent population-based survival rates in oesophageal and gastric cancer.
Lagergren J; Mattsson F
PLoS One; 2012; 7(7):e41352. PubMed ID: 22815994
[TBL] [Abstract][Full Text] [Related]
37. Use of radiotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP) population-based study.
McPhail S; Barclay ME; Swann R; Johnson SA; Alvi R; Barisic A; Bucher O; Creighton N; Denny CA; Dewar RA; Donnelly DW; Dowden JJ; Downie L; Finn N; Gavin AT; Habbous S; Huws DW; Kumar SE; May L; McClure CA; Morrison DS; Møller B; Musto G; Nilssen Y; Saint-Jacques N; Sarker S; Shack L; Tian X; Thomas RJ; Wang H; Woods RR; You H; Zhang B; Lyratzopoulos G;
Lancet Oncol; 2024 Mar; 25(3):352-365. PubMed ID: 38423049
[TBL] [Abstract][Full Text] [Related]
38. Trends in oesophago-gastric cancer incidence in Spain: analysis by subsite and histology.
Aragonés N; Izarzugaza MI; Ramos M; Chirlaque MD; Almar E; Martínez C;
Ann Oncol; 2010 May; 21 Suppl 3():iii69-75. PubMed ID: 20427363
[TBL] [Abstract][Full Text] [Related]
39. Global incidence of oesophageal cancer by histological subtype in 2012.
Arnold M; Soerjomataram I; Ferlay J; Forman D
Gut; 2015 Mar; 64(3):381-7. PubMed ID: 25320104
[TBL] [Abstract][Full Text] [Related]
40. Rising incidence of oesophageal adenocarcinoma in men in Australia.
Lord RV; Law MG; Ward RL; Giles GG; Thomas RJ; Thursfield V
J Gastroenterol Hepatol; 1998 Apr; 13(4):356-62. PubMed ID: 9641297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
